- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow STAVROS KONSTANTINIDES Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 180239 [Title] => Clot-dissolving therapy stops submassive PE [Summary] => INGELHEIM, Germany Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration of patients with submassive pulmonary embolism.
[DatePublished] => 2002-10-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 155682 [Title] => Clot-dissolving therapy improves heart patients [Summary] => ATLANTA, Georgia Administering the clot-dissolving drug alteplase (Actilyse, Boehringer Ingelheim) early during massive pulmonary embolism prevents the disease from worsening, a new clinical trial showed.
Patients who benefited from the treatment had signs of right-heart strain at presentation. Their hearts were laboring to function despite the presence of clots obstructing the pulmonary arteries, but the patients appeared hemodynamically stable or they had normal blood pressure.
[DatePublished] => 2002-04-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
STAVROS KONSTANTINIDES
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 180239 [Title] => Clot-dissolving therapy stops submassive PE [Summary] => INGELHEIM, Germany Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration of patients with submassive pulmonary embolism.
[DatePublished] => 2002-10-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 155682 [Title] => Clot-dissolving therapy improves heart patients [Summary] => ATLANTA, Georgia Administering the clot-dissolving drug alteplase (Actilyse, Boehringer Ingelheim) early during massive pulmonary embolism prevents the disease from worsening, a new clinical trial showed.
Patients who benefited from the treatment had signs of right-heart strain at presentation. Their hearts were laboring to function despite the presence of clots obstructing the pulmonary arteries, but the patients appeared hemodynamically stable or they had normal blood pressure.
[DatePublished] => 2002-04-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
October 17, 2002 - 12:00am
April 1, 2002 - 12:00am
Recommended
The Insurance Commission has placed health maintenance organization Stotsenberg Healthcare Systems Inc.under conservatorship amid its inability to address requirements from the government.
2 days ago
Lotto Sep 21, 2024
EZ2/LVM - 20 17
SUERTRES - 9 2 4
6D Lotto - 6 5 4 8 7 3
6/42 - 20 10 14 23 3 38
P5,940,000.00
Grand Lotto - 6 20 5 28 29 10
P29,700,000.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66